Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoCavco Industries : Annual Report for Fiscal Year Ending March 28, 2026 (Form 10-K)
13m agoPacific Booker Engages Tetra Tech for Morrison Project Technical Review
13m agoQuantumCore Announces Changes to Board of Directors
14m agoSHARC Energy Oversubscribes Closing of Third Tranche of Debenture Exercising 25% Overallotment
14m agoKB HOME OPENS CLOUDBREAK RIDGE, A GATED COLLECTION OF HOMES WITHIN SUMMERLIN, A PREMIER LAS VEGAS MASTER PLAN
Samsung Biologics Co., Ltd. logo

Samsung Biologics Co., Ltd.

About

1,415,000.00KRW+20000.00 +1.43%
Closed • Updated at 21:15 GMT+00:00
Market Cap$42.56B
P/E Ratio34.86
Volume65.3K
Beta0.33
RSI42.24
Gross Margin55.52%
Health TechnologyBiotechnology

Samsung Biologics Co., Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

May 20 2026
Samsung Biologics : 2025 FY Audited Financial Statements (Consolidated)
May 6 2026
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
May 5 2026
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year
Apr 22 2026
Samsung Biologics Reports First Quarter 2026 Financial Results
Mar 31 2026
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Community Chat

Ask AI

6ix6ixAIEvents